Ultimate biodegradability and ecotoxicity of orally administered antidiabetic drugs

被引:39
|
作者
Markiewicz, Marta [1 ]
Jungnickel, Christian [2 ]
Stolte, Stefan [1 ,3 ]
Bialk-Bielinska, Anna [3 ]
Kumirska, Jolanta [3 ]
Mrozik, Wojciech [4 ,5 ]
机构
[1] Univ Bremen, UFT Ctr Environm Res & Technol, Leobener Str, D-28359 Bremen, Germany
[2] Gdansk Univ Technol, Fac Chem, Dept Colloid & Lipid Sci, Ul Narutowicza 11-12, PL-80233 Gdansk, Poland
[3] Univ Gdansk, Fac Chem, Dept Environm Anal, Ul W Stwosza 63, PL-80308 Gdansk, Poland
[4] Newcastle Univ, Sch Civil Engn & Geosci, Cassie Bldg, Newcastle Upon Tyne NE1 7RU, Tyne & Wear, England
[5] Med Univ Gdansk, Fac Pharm, Dept Inorgan Chem, Al Hallera 107, PL-80416 Gdansk, Poland
基金
英国工程与自然科学研究理事会;
关键词
Biodegradation; Ecotoxicity; Pharmaceuticals; Antidiabetic drugs; Sulphonamides; TRANSFORMATION PRODUCT GUANYLUREA; HUMAN PHARMACEUTICALS; MASS-SPECTROMETRY; WASTE-WATER; METFORMIN; IDENTIFICATION; DEGRADATION;
D O I
10.1016/j.jhazmat.2017.03.030
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
Hypoglycaemic pharmaceuticals are recently more and more frequently detected in the environment. In our previous study, we have shown that even though many of them undergo significant primary degradation some are transformed to stable products or undergo such transformation that a large part of the structure is still preserved. One of the main routes of elimination from wastewaters or surface waters is biodegradation and a lack thereof leads to accumulation in the environment. Within this work we tested the ultimate biodegradability of six oral antidiabetics: metformin and its main metabolite guanylurea, acarbose, glibenclamide, gliclazide, glimepiride and repaglinide. We also compared the experimental results obtained in this and accompanying work with models designed to predict biodegradability and showed that these models are only moderately successful. Additionally, we examined these compounds in acute Daphnia magna test to check if they might pose an ecotoxicological threat. Combining the results of biodegradability and toxicity tests allows a preliminary assessment of their potential environmental impact. (C) 2017 Elsevier B.V. All rights reserved.
引用
收藏
页码:154 / 161
页数:8
相关论文
共 50 条
  • [1] WEIGHT CHANGE WITH ORALLY ADMINISTERED ANTIDIABETIC DRUGS
    不详
    JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1970, 213 (10): : 1676 - &
  • [2] Orally administered drugs in the treatment of spasticity
    Campistol, J
    REVISTA DE NEUROLOGIA, 2003, 37 (01) : 70 - 74
  • [3] Lymphatic transport of orally administered drugs
    Reddy, L. Hari Vardhan
    Murthy, R.S.R.
    Indian Journal of Experimental Biology, 2002, 40 (10) : 1097 - 1109
  • [4] Loss of orally administered drugs in GI tract
    Gavhane, Yogeshkumar Nanasaheb
    Yadav, Adhikrao Vyankatrao
    SAUDI PHARMACEUTICAL JOURNAL, 2012, 20 (04) : 331 - 344
  • [5] The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
    Sarah Shugarts
    Leslie Z. Benet
    Pharmaceutical Research, 2009, 26 : 2039 - 2054
  • [6] Drug interactions: not just for orally administered drugs
    Chappell, Catherine A.
    Achilles, Sharon L.
    LANCET HIV, 2019, 6 (09): : E563 - E564
  • [7] The Role of Transporters in the Pharmacokinetics of Orally Administered Drugs
    Shugarts, Sarah
    Benet, Leslie Z.
    PHARMACEUTICAL RESEARCH, 2009, 26 (09) : 2039 - 2054
  • [8] A Microstirring Pill Enhances Bioavailability of Orally Administered Drugs
    Mundaca-Uribe, Rodolfo
    Karshalev, Emil
    Esteban-Fernandez de Avila, Berta
    Wei, Xiaoli
    Nguyen, Bryan
    Litvan, Irene
    Fang, Ronnie H.
    Zhang, Liangfang
    Wang, Joseph
    ADVANCED SCIENCE, 2021, 8 (12)
  • [9] Bioavailability of Orally Administered Drugs After Bariatric Surgery
    Dvorackova, Eliska
    Pilkova, Alena
    Matoulek, Martin
    Slanar, Ondrej
    Hartinger, Jan Miroslav
    CURRENT OBESITY REPORTS, 2024, 13 (01) : 141 - 153
  • [10] Bioavailability of Orally Administered Drugs in Critically Ill Patients
    Forsberg, Johanna
    Bedard, Emma
    Mahmoud, Sherif H.
    JOURNAL OF PHARMACY PRACTICE, 2023, 36 (04) : 967 - 979